Lantern Pharma (NasdaqCM:LTRN) Q4 2025 Earnings call March 30, 2026 04:30 PM ET Company ParticipantsDavid Margrave - CFOPanna Sharma - President and CEOOperatorThe webcast replay of the conference call and webinar will be available on Lantern's website. On today's webcast, we have Lantern Pharma CEO Panna Sharma and CFO David Margrave. Panna will start things off with introductions and an overview of Lantern's strategy and business model and highlight recent achievements in our operations, after which David ...